Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?

To: Cindy Powell who wrote (174)	2/23/1999 11:14:00 PM
From: Zencone	Respond to of 196

Medical Discoveries, Inc. Announces Major International Distribution Agreement for InvisiScar Company Press Release LAYTON, Utah, Feb. 23 /PRNewswire/ -- Medical Discoveries, Inc. (OTC Bulletin Board: MLSC - news) announced today that its newly formed Consumer Products division, MDI HealthCare Systems, Inc., has signed an exclusive distribution agreement with Fox Croft Trading Co., an international pharmaceutical trading company, to sell a minimum of 4,000 units of InvisiScar(TM) a month exclusively in Brazil. This agreement represents a financial commitment of just under $1 million per year. InvisiScar(TM) is a discreet, convenient, effective two-step therapy that combines two proven therapeutic agents to help soften, flatten and diminish unsightly scar tissue. ''This agreement propels InvisiScar(TM) into the estimated $3.5 billion scar management/wound care market and marks a significant financial and sales achievement for the Company since the launching of InvisiScar(TM) last month,'' stated Lee F. Kulas, President and CEO. ''We are looking forward to a long and successful relationship with Fox Croft Trading Co., and remain focused on the potential opportunities with Brazil and other international and domestic markets for our scar management/skin care products.'' InvisiScar(TM) is a discreet, convenient, effective two-step therapy that combines two proven therapeutic agents to help soften, flatten and diminish unsightly scar tissue. Step One: Aqua Cleanse(TM) pretreatment pads are used to cleanse, hydrate and disinfect the skin and soften scar tissue. Step Two: InvisiScar(TM) offers the consumer all the benefits of ''gel sheeting'' without the difficulties associated with its application. InvisiScar(TM) is an invisible, odor-free, moisturizing topical gel that works discretely around-the-clock to soften, flatten, and reduce scar tissue to a more normal color and texture. For further information about InvisiScar(TM) and the other scar management/skin care products provided by MDI HealthCare Systems, Inc., please direct all inquiries as follows: Distribution Availability: Neal G. Ofiesh, Vice President of Sales, (724-334-0500); Ordering Information: (1-877-343-6373); for all other Questions: Troy Fullmer, Director of Operations, (801-771-0523). SOURCE: Medical Discoveries, Inc.